Drug recall · December 5, 2012
Mylan, Tacrolimus Capsules 0.5 mg recall
Why: Failed USP Content Uniformity Requirements: OOS result reported on retained samples.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Mylan, Tacrolimus Capsules 0.5 mg, 100 count bottle, Rx only, Mylan Pharmaceuticals Inc., Morgantown, WV 26505 NDC 0378-2045-01
- Lots / codes
Lots: 3027684 Exp. 5/13, 3027688 Exp. 6/13 2002157 Exp. 9/12
- Quantity
- 15181 bottles.
- Company
- Mylan LLC., Caguas, PR
- Distribution
- Natiowide
- Initiated
- June 29, 2012 · Voluntary: Firm initiated
- Classified
- November 26, 2012
- Reported
- December 5, 2012
- Ended
- April 13, 2017
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Tacrolimus
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.